Quick Answer
RAPID MICRO BIOSYSTEMS, INC. reported Operating Income Loss of -$47.39 million for the year ending 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +5.1% in Operating Income Loss from 2024 to 2025.
- This data is from RAPID MICRO BIOSYSTEMS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$6.01 million | Q3 2020: -$7.58 million | Q1 2021: -$9.69 million | Q2 2021: -$10.86 million | Q3 2021: -$12.12 million | Q1 2022: -$15.00 million | Q2 2022: -$14.07 million | Q3 2022: -$16.89 million | Q1 2023: -$14.87 million | Q2 2023: -$15.05 million | Q3 2023: -$14.45 million | Q1 2024: -$14.27 million | Q2 2024: -$13.38 million | Q3 2024: -$12.04 million | Q1 2025: -$11.66 million | Q2 2025: -$12.15 million | Q3 2025: -$11.37 million.
- Over the full 6 years of available data (2020 to 2025), RAPID MICRO BIOSYSTEMS, INC.'s Operating Income Loss has declined by 55.2%.
- Historical annual values: Fiscal year 2025: -$47.39 million | Fiscal year 2024: -$49.92 million | Fiscal year 2023: -$56.56 million | Fiscal year 2022: -$63.22 million | Fiscal year 2021: -$47.23 million | Fiscal year 2020: -$30.54 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: